Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.

Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2. Nat Chem Biol. 2011 Apr; 7(4):203-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.